Understanding toxic shock syndrome (Q41234193)

28 September 2017

Understanding toxic shock syndrome (English)

1 reference

28 September 2017

2

Marin H Kollef

1 reference

28 September 2017

Jason P Burnham

1

1 reference

28 September 2017

14 May 2015

1 reference

28 September 2017

Intensive Care Medicine

1 reference

28 September 2017

41

1 reference

28 September 2017

9

1 reference

28 September 2017

1707-1710

1 reference

https://scigraph.springernature.com/pub.10.1007/s00134-015-3861-7

28 September 2017

0 references

cites work

Staphylococcal toxic shock syndrome 2000-2006: epidemiology, clinical features, and molecular characteristics

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-3861-7

Epidemiology of severe Streptococcus pyogenes disease in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-3861-7

Clinical spectrum of nonmenstrual toxic shock syndrome (TSS): comparison with menstrual TSS by multivariate discriminant analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-3861-7

Toxic shock syndrome in the United States: surveillance update, 1979 1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-3861-7

Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-3861-7

Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-3861-7

Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-3861-7

Successful treatment of staphylococcal toxic shock syndrome with linezolid: a case report and in vitro evaluation of the production of toxic shock syndrome toxin type 1 in the presence of antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-3861-7

Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-3861-7

Influences of Linezolid, Penicillin, and Clindamycin, Alone and in Combination, on Streptococcal Pyrogenic Exotoxin A Release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-3861-7

Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-3861-7

Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-3861-7

One in five mortality in non-menstrual toxic shock syndrome versus no mortality in menstrual cases in a balanced French series of 55 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-3861-7

Low Level of TSST-1 Antibody in Burn Patients With Toxic Shock Syndrome Caused by Methicillin-Resistant Staphylococcus aureus.

21 January 2018

1 reference

12 December 2020

Detection of staphylococcal enterotoxin B among toxic shock syndrome (TSS)- and non-TSS-associated Staphylococcus aureus isolates

1 reference

12 December 2020

Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989

1 reference

12 December 2020

STAPHYLOCOCCAL ENTEROTOXIN B AND TOXIC-SHOCK SYNDROME TOXIN-1 ARE SIGNIFICANTLY ASSOCIATED WITH NON-MENSTRUAL TSS

1 reference

12 December 2020

Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus

1 reference

12 December 2020

10.1007/S00134-015-3861-7

Identifiers

DOI

1 reference

28 September 2017

1 reference

PubMed ID

25971393